Apparatus and methods for pressure management within a wound chamber

Information

  • Patent Grant
  • 12036353
  • Patent Number
    12,036,353
  • Date Filed
    Monday, September 21, 2020
    4 years ago
  • Date Issued
    Tuesday, July 16, 2024
    5 months ago
  • Inventors
  • Examiners
    • Bouchelle; Laura A
    Agents
    • Cardle; James A
Abstract
A wound therapy apparatus disclosed herein includes a wound interface sealingly securable to a skin surface around a wound bed to form an enclosed space over the wound bed. An inflow fluid pathway and an outflow fluid pathway communicate fluidly with the enclosed space through an inflow port and an outflow port, respectively. The inflow port and the outflow port may be in spaced relation to define a flow path within the enclosed space equivalent in length to a characteristic length of the enclosed space. Pressure sensors may be in communication with the inflow fluid pathway and the outflow fluid pathway to detect inflow pressure pin, and outflow pressure pout.
Description
BACKGROUND OF THE INVENTION
Field

This invention relates to medical devices, and more particularly, to wound therapy apparatus and related methods of operation.


Related Art

Wounds afflict hundreds of millions of people globally. While wounds are often traumatic in origin, wounds may also develop due to underlying physiological conditions such as morbidity of the vascular system. Wound and wound bed, as used herein, includes a localized region of tissue that has been affected by hostile factors, resulting in, for example, cellular abnormality such as swelling, inflammation, degradation, infection, or cell death. The wound bed represents an unhealed wound. In contrast, a healed wound is a skin surface that was previously injured but the focal breach is now entirely sealed and covered by varying amounts of epidermis and scar tissue. FIG. 1 illustrates an exemplary wound bed including some reference anatomy. As illustrated in FIG. 1, the wound bed may include varying degrees of exposure of underlying layers and structures along with possible infections and tissue changes. The wound bed, as illustrated, includes a localized region of tissue that has lost skin and been affected by hostile factors resulting in cellular abnormalities such as swelling, inflammation, degradation, infection, or cell death. The wound bed may include varying degrees of exposure of layers and structures that underlie the skin surface, as illustrated, along with possible infection and tissue changes. The wound bed may lie within a wound boundary that extends around the affected region at the skin surface of the skin. Wound boundary, as used herein, refers to the perimeter of the wound bed at the skin surface of the skin. The wound bed may extend contiguously in depth within the dermis, and the wound bed may extend yet deeper, for example, into subcutaneous fat, and deeper structures. Thus, the wound bed may include undermined flaps, sinuses, tunnels, and fistulae and the surrounding affected tissues.


Current negative pressure wound therapy (NPWT) devices may include an NPWT interface device. The NPWT interface device may include a dressing, a thin flexible sheet of generally fluid impervious polymer that is adhesive coated on portions of a distal side, and a single tube for fluid communication with the dressing. The dressing, may be, for example, cotton gauze, or open-cell foam made from polyvinyl alcohol or polyurethane.


After the dressing is packed into the wound bed, the sheet is then centered over the dressing and wound bed and then secured sealingly adhesively to the skin around the wound bed using the adhesive coating thereby sealing the wound bed and dressing. Finally, an aperture is created in the sheet over the dressing, and a connector and evacuation tube is sealingly engaged with that aperture thus forming the NPWT interface device. Air within a region between the sheet and the wound bed is evacuated through the tube to produce a suction pressure ps within the region that is less than the ambient pressure pamb. The wound bed and surrounding skin contracts as the pressure within the region is decreased by suction pressure ps, which causes the surrounding ambient pressure pamb to compresses the sheet and dressing upon the wound bed. Exudate from the wound bed may be drawn through the dressing and evacuated through the tube.


However, current NPWT devices suffer from various disadvantages. For example, the suction pressure ps within the region is typically alternated between about −125 mm Hg and about −25 mm Hg in current NPWT therapy regimens. However, by analogy, this variation in suction pressure ps is almost as ineffective at removing exudate from the wound bed as removing the content of a bottle by sucking at the mouth of the bottle.


Furthermore, due to the variable distance between the wound bed (which may be located anywhere from head to toe of a patient) and the suction pump (which is often placed by a bedside or carried near a patient's waist if portable), the suction pump and the NPWT interface device are typically connected by a tube of long length to accommodate various relative placements. The likely redundancy of the tube may result in the tube forming a dependent loop that may collect some exudate at low points within the tube, much like an elbow in a drain collects liquid. Evaporation is accelerated in such NPWT interface devices that are repeatedly subjected to suction causing exudate within the tube to evaporate forming a clog that at least partially occludes the tube. Because suction pressure ps is sensed within the tube not directly within the region between the sheet and the wound bed, occlusion of the tube may result in a false indication that proper therapy is being delivered to the wound bed when, in fact, proper therapy is not being delivered to the wound bed. For example, a suction pressure ps of −125 mm Hg may be sensed within the tube proximal of the occlusion, when, in fact, the suction pressure ps is very low or even non-existent distal of the occlusion (e.g., in the region between the sheet and the wound bed).


In order to correct this erroneous sensing problem, certain NPWT interface devices have a tube that includes multiple peripheral lumens formed in the tube peripheral to a central lumen. Fluid is then withdrawn from the region between the sheet and the wound bed through the central lumen, and the peripheral lumens are used for sensing the pressure within the region between the sheet and the wound bed. Pressure in the central lumen is also sensed to detect discrepancies between pressure in the central lumen and pressure in the peripheral lumens. For example, if the suction pressure ps within the region between the sheet and the wound bed sensed through the central lumen is high and the suction pressure ps within the region between the sheet and the wound bed sensed using the peripheral lumens is low, it may then be inferred that an occlusion such as an exudate plug is likely present in the central lumen.


However, such NPWT devices with peripheral lumens also have significant shortcomings. For example, the peripheral lumens by virtue of being small in size and used only for pressure sensing without communication of fluid therethrough may be prone to occlusion such as clogging with exudate, especially given the proximity of the peripheral lumen to the central lumen through which exudate is communicated. Thus, the availability of the peripheral lumens as sensing channels may be unreliable. Furthermore, the peripheral lumens sense suction pressure proximate the central lumen, not at other points within the NPWT interface device. This proximity of the peripheral lumens to the central lumen has, for example, the functional effect of placing a thermostat right next to an airflow inlet vent in a room and hoping to have a selected temperature within the entire room. Accordingly, the peripheral lumens in combination with the central lumen may not provide an accurate indication of the pressure within the region between the sheet and the wound bed.


Accordingly, there is a need for improved apparatus as well as related methods that provide an accurate indication of the pressure within the region between the sheet and the wound bed as well as provide accurate indications of various operational conditions.


BRIEF SUMMARY OF THE INVENTION

These and other needs and disadvantages may be overcome by the apparatus and related methods of use disclosed herein. Additional improvements and advantages may be recognized by those of ordinary skill in the art upon study of the present disclosure.


A wound therapy apparatus disclosed herein includes a wound interface sealingly securable to a skin surface around a wound bed to form an enclosed space over the wound bed, an inflow port disposed about the wound interface to form a portion of an inflow fluid pathway that communicates an inflow fluid into the enclosed space, and an outflow port disposed about the wound interface to form a portion of an outflow fluid pathway that communicates an outflow fluid out of the enclosed space, in various aspects. The outflow port is in spaced relation with the inflow port to define a flow path within the enclosed space having a length equivalent to a characteristic length of the enclosed space, in various aspects. An inflow pressure sensor is in communication with the inflow fluid pathway to detect an inflow pressure pin of the inflow fluid, and an outflow pressure sensor is in communication with the outflow fluid pathway to detect an outflow pressure pout of the outflow fluid, in various aspects. The inflow pressure pin and the outflow pressure pout in combination are indicative of a pressure pa within the enclosed space, in various aspects. In various aspects, the inflow pressure pin of the inflow fluid, a time rate of change of the inflow pressure







dp
in

dt





of the inflow fluid, the outflow pressure pout of the outflow fluid, and a time rate of change of the outflow pressure







dp
out

dt





of the outflow fluid are measured to determine an operational condition of the wound therapy apparatus.


This summary is presented to provide a basic understanding of some aspects of the apparatus and related methods disclosed herein as a prelude to the detailed description that follows below. Accordingly, this summary is not intended to identify key elements of the apparatus and methods disclosed herein or to delineate the scope thereof.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates an exemplary wound bed including various anatomical features thereof;



FIG. 2 illustrates by schematic diagram an exemplary implementation of a wound therapy apparatus;



FIG. 3A illustrates by perspective view portions of a second exemplary implementation of a wound therapy apparatus in an open position;



FIG. 3B illustrates by perspective view the second exemplary implementation of a wound therapy apparatus of FIG. 3A in a closed position;



FIG. 3C illustrates by cross-sectional view portions of the second exemplary implementation of a wound therapy apparatus of FIG. 3A;



FIG. 4A illustrates by perspective view a third exemplary implementation of a wound therapy apparatus;



FIG. 4B illustrates by exploded view the third exemplary implementation of a wound therapy apparatus of FIG. 4A;



FIG. 4C illustrates by cut-away elevation views portions of the third exemplary implementation of a wound therapy apparatus of FIG. 4A;



FIG. 4D illustrates by cut-away elevation views portions of the third exemplary implementation of a wound therapy apparatus of FIG. 4A;



FIG. 4E illustrates by cut-away elevation view the third exemplary implementation of a wound therapy apparatus of FIG. 4A;



FIG. 5 illustrates by plan view portions of a fourth exemplary implementation of a wound therapy apparatus;



FIG. 6 illustrates by plan view portions of a fifth exemplary implementation of a wound therapy apparatus;



FIG. 7 illustrates by plan view portions of a sixth exemplary implementation of a wound therapy apparatus; and,



FIG. 8 illustrates by plan view portions of a seventh exemplary implementation of a wound therapy apparatus.





The Figures are exemplary only, and the implementations illustrated therein are selected to facilitate explanation. The number, position, relationship and dimensions of the elements shown in the Figures to form the various implementations described herein, as well as dimensions and dimensional proportions to conform to specific force, weight, strength, flow and other physical requirements are explained herein or are understandable to those of ordinary skill in the art upon study of this disclosure. Where used in the various Figures, the same numerals designate the same or similar elements. Furthermore, when the terms “top,” “bottom,” “right,” “left,” “forward,” “rear,” “first,” “second,” “inside,” “outside,” and similar terms are used, the terms should be understood in reference to the orientation of the implementations illustrated in the Figures and are utilized only to facilitate description thereof. Use herein of relative terms such as generally, about, approximately, essentially, may be indicative of engineering, manufacturing, or scientific tolerances such as ±0.1%, ±1%, ±2.5%, ±5%, or other such tolerances, as would be recognized by those of ordinary skill in the art upon study of this disclosure.


DETAILED DESCRIPTION OF THE INVENTION

A wound therapy apparatus disclosed herein includes a wound interface sealingly securable to a skin surface around a wound bed to form an enclosed space over the wound bed, an inflow port disposed about the wound interface to form a portion of an inflow fluid pathway that communicates an inflow fluid into the enclosed space, and an outflow port disposed about the wound interface to form a portion of an outflow fluid pathway that communicates an outflow fluid out of the enclosed space, in various aspects. The outflow port is in spaced relation with the inflow port to define a flow path within the enclosed space having a length equivalent to a characteristic length of the enclosed space, in various aspects, so that a combination of an inflow pressure pin of the inflow fluid in the inflow fluid pathway and an outflow pressure pout are measured to measure a pressure pa within the enclosed space at the length equivalent to the characteristic length of the enclosed space. In various aspects, the inflow pressure pin of the inflow fluid, a time rate of change of the inflow pressure







dp
in

dt





of the inflow fluid, the outflow pressure pout of the outflow fluid, and a time rate of change of the outflow pressure







dp
out

dt





of the outflow fluid are measured to determine an operational condition of the wound therapy apparatus. Time rates of change of time rates of change









d
2



p
in



dt
2


,



d
2



p
out



dt
2







(e.g., 2nd derivatives) may be measured, in various aspects.


The pressure pa is the actual pressure within the enclosed space. The characteristic length defines a length scale of the enclosed space, and the characteristic length may be, for example, a diameter, a radius, a diagonal length, a side length, a hydraulic diameter, or a hydraulic radius. In various aspects, because the inflow port and the outflow port are spaced to define the flow path having length within the enclosed space commensurate with the characteristic length, the inflow pressure pin of the inflow fluid and outflow pressure pour of the outflow fluid are indicative of pressure pa within the enclosed space as measured at a length scale commensurate with the characteristic length of the enclosed space. That is, the length at which measurements of the pressure pa within the enclosed space is commensurate with the length scale of the enclosed space, in various aspects. For example, in aspects having a tube that communicates with the enclosed space, the characteristic length of the enclosed space and length of the flow path are both multiples of a diameter of the tube. Such aspects stand in contrast to pressure measurements of pressure pa within the enclosed space at a single location or at multiple locations separated by less than a diameter of the tube.


Fluid, as used herein, includes liquid(s), gas(ses), and combinations thereof. Liquid may include, for example, water, saline solution, proteolytic enzyme solutions, antimicrobial lavages, amniotic fluid, and exudate, and combinations thereof. Gas may include, for example, air, oxygen, nitric oxide, nitrogen, therapeutic or inert gasses, and combinations thereof. Exudate, as used herein, includes, for example, proteinaceous liquids exuded from the wound bed, along with various plasma and blood components. Exudate may also include other liquids used in treating the wound bed or produced by the wound bed or by surrounding tissues.


In various aspects, the term fluid-tight or related terms, as used herein, means sufficiently leak-resistant to allow insufflation or vacuum suction to create a pressure pa within the enclosed space that may be above or below ambient pressure pamb. The term fluid-tight means sufficiently leak-resistant to substantially retain fluids including both gasses and liquids within the enclosed space other than by controlled fluid communication through one or more lumen that fluidly communicate through the wound interface with the enclosed space, in certain aspects. In certain aspects, fluid tight means sufficiently leak-resistant to maintain pressure pa within the enclosed space that may be above or below ambient pressure pamb.


Ambient pressure pamb, as used herein, refers to the pressure in a region surrounding the wound therapy apparatus. Ambient pressure pamb, for example, may refer to atmospheric pressure, hull pressure within an aircraft or submarine where the wound therapy apparatus is being utilized, or pressure maintained generally within a building or other structure where the wound therapy apparatus is being utilized. Ambient pressure pamb may vary, for example, with elevation or weather conditions. Pressure pa within the enclosed space refers to the pressure actually occurring within the enclosed space. Minimum pressure pmin refers to the minimum pressure achieved within the enclosed space of the wound therapy apparatus, and periodically varying of pressure pa, pressure variation, varying pressure, and similar term refer to changes of pressure pa within the enclosed space over time. Maximum pressure pmax refers to the maximum pressure achieved within the enclosed space of the wound therapy apparatus. Pressures such as suction pressure ps, pressure pa, minimum pressure pmin, and maximum pressure pmax and their associated pressure values are as gauge pressure in this disclosure.


As used herein the terms distal and proximal are defined from the point of view of a physician, including various other healthcare providers, treating a patient with the wound therapy apparatus. When so treating the patient, a distal portion of the wound therapy apparatus is oriented toward the patient and a proximal portion of the wound therapy apparatus is oriented toward the physician. A distal portion of a structure is the portion closest to the patient while a proximal portion of the structure is the portion closet to the physician.


Although time rates of change such as








dp
out

dt






and







dp
in

dt






are expressed mathematically as differentials in this disclosure, it should be recognized that such time rates of change may be indicative of various approximations such as finite differences including other discretizations and approximations, and these approximations may be represented digitally in conformance to engineering, manufacturing, or scientific tolerances, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure. For example, the finite difference representation of time rates of change such as








dp
out

dt






and







dp
in

dt






in various implementations may be limited by byte size and may include various errors such as roundoff error and truncation error. In various implementations, quantities such as suction pressure ps, pressure pa, inflow pressure pin, outflow pressure pout, minimum pressure pmin, and maximum pressure pmax and time rates of change of pressure as used in the various mathematical relationships and formulations disclosed herein as well as the various mathematical relationships and formulations disclosed herein may include various errors such as roundoff error and truncation error and may conform to engineering, manufacturing, or scientific tolerances, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure. Quantities such as suction pressure ps, inflow pressure pin, and outflow pressure pout as measured may be in the form of averages, median values, or other statistical representations of a plurality of measurements made using a sensor, in various implementations, and may include errors inherent in measurement by the sensor as well as errors in digital representations.



FIG. 2 illustrates exemplary wound therapy apparatus 10. As illustrated in FIG. 2, wound interface 15 of wound therapy apparatus 10 is secured to skin surface 11 to define enclosed space 17 that is fluid tight over a wound bed (e.g., see FIG. 1; also wound bed 213 in FIG. 4E). In this implementation, wound therapy apparatus 10 includes oxygen source 82, air source 83, and liquid source 84 in fluid communication with enclosed space 17 of wound interface 15 via inflow fluid pathway 26 through inflow port 42 as controlled by valve 88. Inflow fluid pathway 26 includes inflow port 42. Valve 88, in turn, may be positioned by controller 87 to control the communication of oxygen 22 from oxygen source 82, air 23 from air source 83, liquid 24 from liquid source 84, or combinations of oxygen 22, air 23, and/or liquid 24 into enclosed space 17 as inflow fluid 16 via fluid pathway 26, as illustrated.


Pump 88 under control of controller 87 withdraws outflow fluid 18 from enclosed space 17 via fluid pathway 28, and outflow fluid pathway 28 includes outflow port 44. Outflow fluid 18 may include, for example, inflow fluid 16 and exudate 19, as illustrated. Liquid, such as liquid 24 and exudate 19, in outflow fluid 18 is captured in reservoir 57 of canister 50 as outflow fluid 18 is communicated through canister 50 by pump 89, and only gaseous portions of outflow fluid 18 are communicated from canister 50 to pump 89, in this implementation. Gaseous portions of outflow fluid 18 are discharged into the ambient environment by pump 89, as illustrated. Canister 50 including reservoir 57 may be omitted, for example, when the quantity of exudate 19 is minimal or there is no liquid, such as liquid 24 from liquid source 84, in outflow fluid 18. Canister 50 may be replaceable and disposable, in certain implementations.


Inflow pressure sensor 91 is in operable communication with inflow fluid pathway 26 to detect inflow pressure pin of inflow fluid 16 and the time rate of change of inflow pressure








dp
in

dt

.





Outflow pressure sensor 93 is in operable communication with outflow fluid pathway 28 to detect outflow pressure pout of outflow fluid 18 the time rate of change of outflow pressure








dp
out

dt

.





Inflow pressure sensor 91 may communicate with inflow fluid pathway 26 at one or more locations along inflow fluid pathway 26, for example, at or about oxygen source 82, air source 83, liquid source 84, valve 88, and/or within or about inflow port 42. Outflow pressure sensor 93 may communicate with outflow fluid pathway 28 at one or more locations along outflow fluid pathway, for example, within or about outflow port 44, reservoir 57 of canister 50, and/or suction side of pump 89.


Inflow port 42 and outflow port 44 are spaced length L1 apart, and enclosed space 17 has characteristic length D1, as illustrated. Characteristic length D1 is a characteristic length of enclosed space 17 such as, for example, diameter, radius, diagonal length, side length, hydraulic diameter, hydraulic radius, and so forth, that defines a scale of enclosed space 17. Because inflow port 42 is located length L1 from outflow port 44, inflow pressure pin detected by inflow pressure sensor 91 and outflow pressure pout detected by outflow pressure sensor 93 are indicative of pressure pa at locations length L1 apart in enclosed space 17 proximate inflow port 42 and proximate outflow port 44, respectively. In various implementations, length L1 may be commensurate with characteristic length D1 of enclosed space 17, so that the inflow pressure pin detected by inflow pressure sensor 91 and outflow pressure pout detected by outflow pressure sensor 93 are commensurate with the scale of enclosed space 17. That is, in contrast to a single pressure measurement or multiple pressure measurements proximate one another, in exemplary wound therapy apparatus 10 pressure pa within enclosed space 17 is measured by measuring inflow pressure pin and outflow pressure pout at locations length L1 apart where length L1 is commensurate with characteristic length D1 of enclosed space 17. In various implementations, length L1 may be, for example, greater than 50% of characteristic length D1. In various implementations, length L1 may be, for example, greater than 80% of characteristic length D1. In various implementations, length L1 may be, for example, greater than 90% of characteristic length D1.


Note that inflow pressure sensor 91 and outflow pressure sensor 93 are illustrated as separate pressure sensors for purposes of explanation. In various implementations, inflow pressure sensor 91 and outflow pressure sensor 93 may be formed as a single pressure sensor configured to detect inflow pressure pin and outflow pressure pout, or inflow pressure sensor 91 or outflow pressure sensor 93 may be formed as multiple pressure sensors.


Controller 87 communicates operably with valve 88, pump 89, inflow pressure sensor 91, outflow pressure sensor 93, via communication pathway 61, 62, 63, 65, respectively, to control operations of valve 88, pump 89, inflow pressure sensor 91, and outflow pressure sensor 93 in order to deliver a therapy regimen within enclosed space 17. Controller 87 communicates operably with user I/O 86 to allow a user to control the operations of wound therapy apparatus 10, for example, to select the therapy regimen delivered within enclosed space 17. Controller 87 may control the operation of wound therapy apparatus 10, at least in part, based upon data 74 communicated to controller 87 from user I/O 86 via communication pathway 64, and controller 87 may control the operation of wound therapy apparatus 10, at least in part, based upon data 71, 72, 73, 75 communicated between controller 87 and valve 88, pump 89, inflow pressure sensor 91, and outflow pressure sensor 93 via communication pathways 61, 62, 63, 65, respectively.


Data 74 input from the user via user I/O 86 is communicated to controller 87, for example, in order to allow the user to direct the operation of wound therapy apparatus 10. At least in part in response to data 74, controller 87 may direct delivery of various therapy regimens within enclosed space 17 of wound interface 15. For example, controller 87 may variously select inflow fluid 16 as oxygen 22 from oxygen source 82, air 23 from air source 83, liquid 24 from liquid source 84, or combinations thereof, and controller 87 may control the actual pressure pa within enclosed space 17 by controlling the inflow of inflow fluid 16 into enclosed space 17 and the withdrawal of outflow fluid 18 from enclosed space 17 through operations of valve 88 and pump 89. Controller 87 may alter the selection of inflow fluid 16 as oxygen 22 from oxygen source 82, air 23 from air source 83, liquid 24 from liquid source 84, combinations thereof, and/or the controller 87 may alter the pressure pa within enclosed space 17 over time according to the therapy regimen(s) being delivered. As examples, at certain times during the therapy regimen, (i) outflow fluid 18 is being withdrawn from enclosed space 17 while no inflow fluid 16 is being flowed into enclosed space 17 in order to reduce pressure pa to minimum pressure pmin; (ii) inflow fluid 16 is being flowed into enclosed space 17 while no outflow fluid 18 is being withdrawn from the enclosed space 17 in order to increase pressure pa to maximum pressure pmax; or, (iii) no inflow fluid 16 is being flowed into the enclosed space 17 and no outflow fluid 18 is being withdrawn from the enclosed space 17 as pressure pa is held at minimum pressure pmin or at maximum pressure pmax.


Data 71 may be indicative of the operation of valve 88, for example, the position of valve 88—fully closed, fully open, intermediate of fully closed and fully open, allowing flow of oxygen 22 from oxygen source 82, allowing flow of air 23 from air source 83, allowing flow of liquid 23 from liquid source 84. Controller 87 may communicate data 71 with valve 88 to alter the operation of valve 88, for example, to select inflow fluid 16 as oxygen 22 from oxygen source 82, air 23 from air source 83, liquid 23 from liquid source 84, and combinations thereof. Controller 87 may communicate data 71 with valve 88 to alter the operation of valve 88, for example, to regulate, at least in part, the rate at which oxygen 22, air 23, liquid 24, or combinations thereof are flowed into enclosed space 17 as inflow fluid 16. It should be recognized that valve 88 is illustrated as a single valve 88 for purposes of explanation, and that, in various implementations, valve 88 may be formed as one or more valves of various types in various arrangements, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure. For example, valve 88 may include one or more valves disposed about wound therapy apparatus to select inflow fluid 16 as gas 22, liquid 24, combinations of gas 22 and liquid 24, to regulate, at least in part, the inflow of inflow fluid 16 into enclosed space 17 of wound interface 15, and to regulate, at least in part, the withdrawal of outflow fluid 18 from enclosed space 17 of wound interface 15.


Data 72 communicated from pump 89 to controller 87 may be indicative of the operation of pump 89, for example, rate of operation, and quantity of electrical power being supplied. Pump 89 may be, for example, a centrifugal pump, positive displacement pump, or peristaltic pump, or multiple pumps of various types, in various implementations, and rate of operation refers to rate of rotation, rate of displacement, rate of contraction, etc. as appropriate. Data 72 communicated from controller 87 to pump 89 may alter the operation of pump 89, for example, setting pump 89 in an ON state, setting pump 89 in an OFF state, or controlling the rate of operation of pump 89 in order to control, at least in part, the withdrawal of outflow fluid 18 from enclosed space 17 including the rate at which outflow fluid 18 is withdrawn.


Data 73 indicative of the inflow pressure pin and/or the time rate of change of inflow pressure







dp
in

dt





detected by inflow pressure sensor 91 is communicated with controller 87 via communication pathway 63, and data 75 indicative of the outflow pressure pout and/or the time rate of change of outflow pressure







dp
out

dt





detected by outflow pressure sensor 93 is communicated with controller 87 via communication pathway 65, as illustrated. Controller 87 may communicate data 73 with inflow pressure sensor 91 to control the operation of inflow pressure sensor 91 such as, for example, the frequency at which inflow pressure pin is detected and locations along inflow fluid pathway 26 at which inflow pressure pin is detected. Controller 87 may communicate data 75 with outflow pressure sensor 93 to control the operation of outflow pressure sensor 93 such as, for example, the frequency at which outflow pressure pout is detected and locations along outflow fluid pathway 28 at which outflow pressure pout is detected. Controller 87 may control the operation of valve 88 in combination with the operation of pump 89 in order to achieve a specified pressure pa within enclosed space 17 as may be indicated by the inflow pressure pin detected by inflow pressure sensor 91 and outflow pressure pout detected by outflow pressure sensor 93.


Controller 87 may include, for example, a processor, memory, software operably communicating with the processor, A/D converter, D/A converter, clock, I/O connectors, and so forth, and controller 87 may be configured for example, as a single chip or as an array of chips disposed about a circuit board, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure. In some implementations, controller 87 may be configured, at least in part, as software operatively received by a computer, and the computer may, for example, communicate by network with valve 88, pump 89, inflow pressure sensor 91, and outflow pressure sensor 93.


User I/O 86 may include various switches, push buttons, dials, sliders, graphs, and so forth, whether virtual or physical, for obtaining data 74 from the user. In certain implementations, user I/O 86 may be formed, at least in part, as software operably received by a computer. Controller 87 may communicate data 74 to user I/O 86 that may be indicative of the operation of wound therapy apparatus 10, and user I/O 86 may display data 74 to the user using physical display(s), virtual display(s), and combinations thereof.


Oxygen source 82 may be, for example, a cylinder of oxygen, an oxygen bag, an oxygen generator, or mains oxygen. Air source 83, may be, for example, ambient air at ambient pressure or compressed air such as a cylinder of air or mains air. Liquid source 84 may be, for example, a container of liquid or mains supply of liquid. Oxygen source 82, air source 83, and liquid source 84 may include various traps, filters, fittings, and so forth, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure.


Inflow fluid 16 may be communicated under pressure of oxygen source 82 (e.g., a tank of compressed gas), pressure of air source 83, pressure of liquid source 84 (e.g., piezometric head at liquid source), with respect to pressure pa within enclosed space 17, suction of pump 89, and combinations thereof.


Wound therapy apparatus 10 may include various fluid conveyances, for example hoses, pipes, valves, tubing, connectors, pressure regulators, plenums, and various other fittings, that form inflow fluid pathway 26 for the communication of oxygen 22, air 23, and liquid 24 from gas source 82, air source 83, and liquid source 84, respectively, to enclosed space 17 of wound interface 15 as inflow fluid 16 and form outflow fluid pathway 28 for the communication of outflow fluid 18 withdrawn from enclosed space 17 of wound interface 15. Note that in various other implementations, at least one of inflow port 42 and outflow port 44 may be used for monitoring directly or indirectly parameters within the enclosed space such as pressure pa, temperature, humidity, pH, tissue oxygenation level, blood flow, etc. to affect the therapy regimen delivered to the wound bed.


Communication pathways 61, 62, 63, 64, 65 may be, for example, wired, wireless, optical (e.g., fiberoptic, infrared), networked (e.g., Internet), or various combinations thereof, in various implementations. Valve 88, pump 89, inflow pressure sensor 91, and outflow pressure sensor 93 may include, for example, A/D converters, D/A converters, actuators, solenoids, stepper motors, microprocessors, to control the operations of valve 88, pump 89, inflow pressures sensor 91, and outflow pressure sensor 93 using data 71, 72, 73, 75 respectively, or to communicated data 71, 72, 73, 75 to controller 87 indicative of the operation of valve 88, pump 89, inflow pressure sensor 91, and outflow pressure sensor 93, as would be readily recognized by those of ordinary skill in the art upon study of the present disclosure. Data 71, 72, 73, 74, 75 may be digital, analog, or combinations thereof, in various implementations.


Power source 97 includes one or more source(s) of electrical power disposed about wound therapy apparatus 10 in electrical communication with wound therapy apparatus 10 including user I/O 86, controller 87, valve 88, pump 89, inflow pressure sensor 91, and outflow pressure sensor 93 to flow electrical power thereupon. Power source 97 may be, for example, mains electric, battery, or combinations of mains electric and battery, and power source 97 may include, for example, a transformer, an inverter, a rectifier, filter(s), surge protector(s), and so forth, as would be readily recognized by those of ordinary skill in the art upon study of the present disclosure. Wound therapy apparatus 10 may include various other fluid communication, data communication, electrical communication, and other pathways, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure.



FIGS. 3A, 3B, 3C illustrate exemplary wound therapy apparatus 100. As illustrated in FIGS. 3A, 3B, exemplary wound therapy apparatus 100 includes wound interface 115, and wound interface 115 includes base 120, cushion 130, and cover 140, with cushion 130 secured circumferentially about the perimeter of base 120 to enclose the perimeter of base 120, and cover 140 secured hingedly to base 120 by hinge 147.


In various implementations, base 120 may be formed, for example, of one or more medical polymers including, for example, ABS, polystyrene or polypropylene, and base 120 may be structurally rigid. Cover 140 may be transparent, at least in part, to allow visual inspection of enclosed space 117 including a wound bed, such as wound bed 213 (see FIG. 4E; also see FIG. 1), and portions of skin surface 111 enclosed within enclosed space 117. Cover 140 may be formed, for example, from polycarbonate, acrylic, or similar clear polymer material such as copolyester available as Eastman Tritan™ from the Eastman Chemical Co.


As illustrated in FIGS. 3A, 3B, cushion 130 is annular shaped with footprint corresponding to that of a perimeter of base 120, as illustrated. Distal portions of cushion 130 may be secured sealingly adhesively around the entire perimeter to a skin surface, and proximal portions of cushion 130 are secured sealingly to base 120 around the entire perimeter of base 120. Cushion 130 cushions the wound interface 115 against the skin surface, and sealingly conforms to a contour of skin surface 111, in this implementation. In some implementations, cushion 130 may be formed, for example, of rubber or a polymer such as PVC or silicone, and cushion 130 may include an inner inflatable chamber. In such implementations, fluid, including air or other gasses or liquids within the inner inflatable chamber may be regulated to inflate cushion 130 to a desired level of cushioning and sealing of wound interface 115 with respect to the skin surface 111. In other implementations, cushion 130 may be formed, for example, of various compressible, conformable, fluid-impervious closed cell foams.


Cover 140 is hingedly attached to base 120 by hinge 147 that allows cover 140 to be positionable between open position 103, illustrated in FIG. 3A, and closed position 101, illustrated in FIG. 3B, to disengage or to engage sealingly, respectively, cover 140 with portions of base 120. Hinge 147 may be, for example, a living hinge, pinned hinge, snap-fit disengageable coupling, or other hinge, as would be readily understood by one of ordinary skill in the art upon study of this disclosure. Cover 140 may be engaged with base 120 by various other mechanisms such as a threaded engagement, or frictional engagement, in other implementations, that allow cover 140 to be sealingly engaged with base 120 and allow cover 140 to be disengaged from base 120. Cover 140 may be removably or non-removably engaged with base 120, in various implementations. Various seals, compression fittings, and so forth may be provided about cover 140, base 120, or cover 140 and base 120 to sealingly engage cover 140 with base 120 when cover 140 is positioned in closed position 101. Note that hinge 147 is optional, and may be omitted in certain implementations, for example, when no direct intervention to the wound bed is contemplated.


As illustrated in FIG. 3B, with cover 140 in closed position 101 and distal portions of cushion 130 secured circumferentially, sealingly, adhesively to skin surface 111, wound interface 115 defines enclosed space 117 that is fluid-tight. As illustrated in FIG. 3A, cover 140 may be positioned in open position 103 to conduct various direct interventions into enclosed space 117. Such direct interventions may include, for example, application of medicament to the wound bed and surrounding skin, debridement of necrotic tissue using medical maggots, and placement of a skin graft including other tissue graft onto the wound bed.


Base 120, as illustrated, has an annular shape, as illustrated in FIGS. 3A, 3B, 3C, to form a circular shaped enclosed space. It should be understood that wound interface 115, may assume other geometric shapes such as rectangular, polygonal, or ovoid, to enclose various shaped wounds or regions of skin surface 111, in various other implementations. The term “annular” as used in this disclosure is intended to describe these other geometric shapes, such as, for example, a polygonal, rectangular, or ovoid, base 120 surrounding enclosed space 117.


Inflow port 142 and outflow port 144 are disposed about cover 140, as illustrated, to fluidly communicate with enclosed space 117 when cover 140 is in closed position 101. As illustrated in FIG. 3C, inflow port 142 and outflow port 144 are spaced length L2 apart, and enclosed space 117 has characteristic length D2, which is a radius of enclosed space 117. Lumen 143 of inflow part 142 has diameter d1 and lumen 145 of outflow port 144 has diameter d2, as illustrated in FIG. 3C. Enclosed space 117 is circular in shape in this implementation, with inflow port 142 located proximate periphery 163 of enclosed space 117, and outflow port 144, located proximate center 161 of enclosed space 117. In other implementations, outflow port 144 may be located proximate periphery 163 and inflow port 142 may be located proximate center 161.


Fluid communication with inflow port 142 and with outflow port 144 may be at least in part via tubing (not shown) including hoses, pipes, valves, and various other fluid conveyances and fittings that may cooperate with inflow port 142 and outflow port 144, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure.


Dressing 150, which is cylindrical in shape, extends forth from cover 140 to contact the wound bed when cover is in closed position 101, in this implementation. Dressing 150 may be variously sized to occupy various portions of enclosed space 117, and dressing 150 may be a therapeutic or protective material configured to intermittently contact the wound bed. Dressing 150 may be formed, for example, of cotton, absorbent foam, or fabric, and dressing 150 absorbs exudate 119 while allowing the transmission of fluids therethrough, in this implementation.


Inflow port 142 is located proximate periphery 163 to introduce inflow fluid 116 into enclosed space 117 via lumen 143 of inflow port 142. Outflow port 144 is positioned at center 161 so that lumen 145 of outflow port 144 fluidly communicates with dressing 150 for withdrawal of outflow fluid 118 from enclosed space 117. Outflow fluid 118 may include exudate, such as exudate 19, withdrawn from dressing 150, as well as inflow fluid 116 and other liquids and gasses that may be present within enclosed space 117. Thus, inflow fluid 116 inflows into enclosed space 117 via lumen 143 of inflow port 142 at periphery 163 of enclosed space 117, and outflow fluid 118 withdrawn from enclosed space 117 via lumen 145 of outflow port 144 at center 161 of enclosed space 117, so that fluid flow is generally from periphery 163 to center 161 of enclosed space 117 along flow path 171 with length L2≈D2, in this implementation. Length L2 of flow path 171 may be multiple times the diameter d1 of lumen 143 of inflow part 142 and length L2 of flow path 171 may be multiple times the diameter d2 of lumen 145 of outflow port 144. For example, length L2 of flow path 171 may be at least 10 times the diameter d1 of lumen 143 of inflow part 142. Length L2 of flow path 171 may be at least 100 times the diameter d1 of lumen 143 of inflow part 142, in certain implementations. In various implementations, length L2 of flow path 171 may be greater than 50% of characteristic length D2. In various implementations, length L2 of flow path 171 may be greater than 80% of characteristic length D2. In various implementations, length L2 of flow path 171 may be greater than 90% of characteristic length D2.


An exemplary implementation of a wound therapy apparatus 200 that includes wound interface 215 is illustrated in FIGS. 4A, 4B, 4C, 4D, 4E wherein wound interface 215 includes sheet 220, inflow port 242, outflow port 244, and dressing 250. Sheet 220 of wound interface 215 may be attached to skin surface 211 to enclose wound bed 213 at skin surface 211, with the entirety of wound boundary 212 enclosed by sheet 220, as illustrated in FIG. 4E. Distal side 222 of sheet 220 faces wound bed 213, and adhesive 290 on at least portions of distal side 222 secures sheet 220 to skin surface 211 thereby defining portions of enclosed space 217, as illustrated in FIG. 4E. Dressing 250 is packed into wound bed 213 and covered by sheet 220, as illustrated. Enclosed space 217 includes at least portions of wound bed 213, as illustrated. Sheet 220 may be made of a single layer of material such as polyurethane, in some implementations, or sheet 220 may be made of multiple layers of material, in other implementations.


As illustrated in FIG. 4E, inflow port 242 and outflow port 244 are in fluid communication with enclosed space 217 between distal side 222 of sheet 220 and proximal side 224 of sheet 220 through lumen 243, 245 formed within inflow port 242 and outflow port 244 and through apertures 223, 225 formed in sheet 220, respectively. Lumen 243, 245 have diameters d3, d4, respectively, as illustrated. Inflow fluid 216 may be flowed into enclosed space 217 via lumen 243 of inflow port 242 and outflow fluid 218 including exudate, such as exudate 19, may be withdrawn from enclosed space 217 via lumen 245 of outflow port 244.


Inflow of inflow fluid 216 into enclosed space 217 via lumen 243 of inflow port 242 and withdrawal of outflow fluid 218 from enclosed space 217 via lumen 245 of outflow port 244 may be sequential with one another, meaning inflow fluid 216 is not being inflowed into enclosed space 217 simultaneously with outflow fluid 218 being withdrawn from enclosed space 217. Inflow fluid 216 may be being inflowed into enclosed space 217 while no outflow fluid 218 is being withdrawn from enclosed space 217, outflow fluid 218 may be being withdrawn from enclosed space 217 while no inflow fluid 216 is being inflowed into enclosed space 217, or no inflow fluid 216 is being inflow into enclosed space 217 and no outflow fluid 218 is being withdrawn from enclosed space 217, in various implementations.


Inflow port 242 and outflow port 244 are spaced length L3 apart to form flow path 271, and enclosed space 217 has characteristic length D3, as illustrated. Inflow port 242 and outflow port 244 are located proximate opposing ends of enclosed space 217, in this implementation, to form flow path 271 of length L3 where length L3 is commensurate with characteristic length D3 (e.g., D3≈L3). implementation. Length L3 of flow path 271 may be multiple times the diameter d3 of lumen 243 of inflow part 242 and length L3 of flow path 271 may be multiple times the diameter d4 of lumen 245 of outflow port 244. For example, length L3 of flow path 271 may be at least 10 times the diameter d3 of lumen 243 of inflow part 142. In various implementations, length L3 of flow path 271 may be greater than 95% of characteristic length D3 of enclosed space 217.


As illustrated in FIG. 4B, sheet 220 of wound therapy apparatus 200 may be supplied with carrier 284 in adhesive engagement with proximal side 224 of sheet 220 and liners 282a, 282b, 282c in adhesive engagement with distal side 222 of sheet 220. Carrier 284 may be made of paper or thin polymer sheet and carrier 284 is used to preserve the shape of sheet 220, which may be thin and prone to becoming entangled with itself. Liners 282a, 282b, 282c may be made of paper or thin polymer sheet and cover distal side 222 of sheet 220 including adhesive 290 until deployment of wound interface 215. For example, as wound interface 215 is deployed, dressing 250 is placed in wound bed 213. Then, liner 282a is peelingly removed from distal side 222 of sheet 220 to expose a portion of adhesive 290 on distal side 222. The portion of adhesive 290 thus exposed is biased against skin surface 211 thereby anchoring sheet 220 to skin surface 211 by adhesive attachment. With sheet 220 anchored to skin surface 211, liners 282b, 282c are then removed and portions of adhesive 290 thus exposed are biased against skin surface 211 to attach distal side 222 of sheet 220 to skin surface 211. Sheet 220 covers dressing 250 and wound bed 213 and is adhesively attached to skin surface 211 around its perimeter in a fluid tight manner thus defining enclosed space 217. With sheet 220 attached to skin surface 211, carrier 284 is then removed from proximal side 224 of sheet 220. Inflow port 242 and outflow port 244 are then adhesively attached to proximal side 224 of sheet 220 using adhesive 292a, 292b on flanges 246, 248 illustrated in FIGS. 4C, 4D, respectively. When attached to proximal side 224 of sheet 220, inflow port 242 and outflow port 244 are placed with lumen 243, 245 aligned with apertures 223, 225 in sheet 220, respectively, to allow lumen 243, 245 to fluidly communicate with enclosed space 217 through apertures 223, 225 in sheet 220, as illustrated in FIG. 4E.



FIGS. 5, 6, 7, 8 illustrate exemplary wound therapy apparatus 300, 400, 500, 600, respectively. As illustrated in FIG. 5, wound therapy apparatus 300 includes wound interface 315, and wound interface 315 includes sheet 320 that overlays dressing 350 that has an elongated rectangular shape, and, thus, enclosed space 317 has an elongated rectangular shape of longitudinal characteristic length D4. Inflow port 342 and outflow port 344 are set apart by length L4 and located proximate ends of the elongated rectangular shape for form flow path 371 of length L4 that fluid traverses between inflow port 342 and outflow port 344. Thus, inflow port 342 and outflow port 344 communicate fluidly with enclosed space 317 including dressing 350 proximate ends of the elongated rectangular shape so that length L4 of flow path 371 is approximately equal to characteristic length D4 (e.g., D4≈L4). Thus, inflow fluid 316 inflow into enclosed space 317 through inflow port 342 is communicated along flow path 371 that is the length of the elongated rectangular shaped enclosed space 317 for withdrawal as at least a portion of outflow fluid 318 through outflow port 344, in this implementation.


As illustrated in FIG. 6, wound therapy apparatus 400 includes wound interface 415 that has a square shape, and wound interface 415 includes sheet 420 that overlays dressing 450 shaped as an irregular pentagon (e.g., an isosceles right pentagon) in conformance to the shape of enclosed space 417. Enclosed space 417 has diagonal characteristic length D5, in this implementation. Inflow port 442 and outflow port 444 are located proximate opposite corners of the irregular pentagonal enclosed space 417 set apart from one another by length L5, as illustrated. Length L5 is approximately equal to diagonal characteristic length D5 (e.g., D5≈L5), in this implementation. Inflow fluid 416 inflow into enclosed space 417 through inflow port 442 is communicated along flow path 471 with length L5 for withdrawal as at least a portion of outflow fluid 418 through outflow port 444, in this implementation. In implementations of wound therapy apparatus having an irregular polygonal shape, the characteristic length may be defined as a longest diagonal of the irregular polygonal shape.


As illustrated in FIG. 7, wound therapy apparatus 500 includes wound interface 515 that has a square shape, and wound interface 515 includes sheet 520 that overlays dressing 550 also of rectangular shape in conformance to the shape of sheet 520. Enclosed space 517 is thus rectangular in shape with diagonal characteristic length D6, in this implementation. Inflow port 542 and outflow port 544 are located at opposite corners of the square shaped enclosed space 517 set apart from one another by length L6. Length L6 is approximately equal to diagonal characteristic length D6 (e.g., D6≈L6), in this implementation. Thus, inflow fluid 516 is communicated into enclosed space 517 through inflow port 542 and is communicated along flow path 571 with length L6 for withdrawal as at least a portion of outflow fluid 518 through outflow port 544, in this implementation.


As illustrated in FIG. 8, wound therapy apparatus 600 includes wound interface 615, and wound interface 615 includes sheet 620 that overlays dressing 650. In this implementation, wound interface 615 is designed for application to a wound bed, such as wound bed 213 (also see FIG. 1), located about a heel (e.g., a decubitus ulcer of the heel), and is shaped accordingly. Enclosed space 617 includes U-shaped barrier 629, as illustrated, interposed between inflow port 642 and outflow port 644, to define enclosed space 617 having somewhat of an hourglass shape with mismatched hourglass chambers and characteristic length D7. Inflow port 642 and outflow port 644 are located proximate one another on opposing sides of U-shaped barrier 629. Because of U-shaped barrier 629, inflow fluid 616 is communicated into enclosed space 617 through inflow port 642, along pathway 671 of length L7 within enclosed space 617 for withdrawal as outflow fluid 618 through outflow port 644, in this implementation. Length L7 is approximately equal to characteristic length D7 (e.g., D7≈L7), in this implementation.


In operation of a wound therapy apparatus, such as wound therapy apparatus 10, 100, 200, 300, 400, 500, 600, a wound interface, such as wound interface 15, 115, 215, 315, 415, 515, 615 is attached to a skin surface, such as skin surface 11, 111, 211, to enclose a wound bed, such as wound bed 213 (also see FIG. 1), within an enclosed space, such as enclosed space 17, 117, 217, 317, 417, 517, 617. An inflow fluid pathway, such as inflow fluid pathway 26, is then placed in communication with the enclosed space through an inflow port, such as inflow port 42, 142, 242, 342, 442, 542, 642, and an outflow fluid pathway, such as outflow fluid pathway 28, is then placed in communication with the enclosed space through an outflow port, such as outflow port 44, 144, 244, 344, 444, 544, 644. Inflow fluid, such as inflow fluid 16, 116, 216, 316, 416, 516, 616, may then be communicated into the enclosed space via the inflow fluid pathway through the inflow port, and outflow fluid, such as outflow fluid 18, 118, 218, 318, 418, 518, 618, may be withdrawn from the enclosed space through the outflow port via the outflow fluid pathway in order to deliver a therapy regimen to the wound bed. Liquid, such as liquid 24 and exudate 19, entrained in the outflow fluid may be collected in a reservoir of a canister, such as reservoir 57 of canister 50. The therapy regimen may be selected by a user and communicated to a controller, such as controller 87, using a user I/O, such as user I/O 86.


As part of the therapy regimen, the inflow fluid may include oxygen from an oxygen source, such as oxygen 22 from oxygen source 82, air from an air source, such as air 23 from air source 83, liquid from a liquid source, such as liquid 24 from liquid source 84, or various combinations of oxygen, air, or liquid. The controller may select oxygen, air, liquid, or various combinations thereof as inflow fluid by positioning a valve, such as valve 88. The controller may regulate the inflow of inflow fluid into the enclosed space and withdrawal of outflow fluid from the enclosed space by regulating the valve and by regulating a pump, such as pump 87, in order to deliver the therapy regimen.


An inflow pressure sensor, such as inflow pressure sensor 91, is in operable communication with the inflow fluid pathway to detect inflow pressure pin of the inflow fluid and the time rate of change of inflow pressure







dp
in

dt





of the inflow fluid in the inflow fluid pathway. An outflow pressure sensor, such as outflow pressure sensor 93, is in operable communication with the outflow fluid pathway to detect outflow pressure pout of the outflow fluid and the time rate of change of outflow pressure







dp
out

dt





of the outflow fluid in the outflow fluid pathway. The controller may operate the valve and the pump and otherwise regulate the operation of the wound therapy apparatus using data, such as data 73, from the inflow pressure sensor and using data, such as data 75, from the outflow pressure sensor, where the data are indicative of inflow pressure pin of the inflow fluid, the time rate of change of inflow pressure







dp
in

dt





of the inflow fluid, outflow pressure pout of the outflow fluid, and the time rate of change of outflow pressure







dp
out

dt





of the outflow fluid.


Various operational conditions of wound therapy apparatus may be detected using the inflow pressure pin of the inflow fluid, the time rate of change of inflow pressure







dp
in

dt





of the inflow fluid, outflow pressure pout of the outflow fluid, and the time rate of change of outflow pressure







dp
out

dt





of the outflow fluid. Hysteresis of changes in the inflow pressure pin, changes in the outflow pressure pout, the time rate of change of inflow pressure








dp
in

dt

,





the time rate of change of outflow pressure







dp
out

dt





alone or in combination may be indicative of various operational conditions of the wound therapy apparatus including the wound bed.


In the following examples of exemplary operational conditions, it is considered that net fluid is being withdrawn from the enclosed space—the withdrawal of outflow fluid is greater than the inflow of inflow fluid so that pressure pa within the enclosed space is being decreased toward minimum pressure pmin. Examples of operational conditions, without limitation, include:


i) Normal Operation.


Inflow pressure pin of the inflow fluid in the inflow fluid pathway is generally equal to the outflow pressure pout of the outflow fluid and therefor indicative of pressure pa within the enclosed space. Mathematically, this may be stated as:

pin≈pa≈pout  (1)

or

|pin−pout<ε  (2)

where ε represents a sensitivity. The time rate of change of the inflow pressure pin generally tracks the time rate of change in outflow pressure pout. That is:
















dp
in

dt



-




dp
out

dt






<
δ




(
3
)








where δ represents another sensitivity. Note that the brackets in the form of vertical lines (e.g., | |) denote absolute values of the quantities enclosed therein. Under normal operational conditions, the inflow pressure pin detected by the inflow pressure sensor and the outflow pressure pout detected by the outflow pressure sensor are indicative of pressure pa in the enclosed space proximate the inflow port and proximate the outflow port, respectively. The inflow port and the outflow port are separated by a length, such as length L1, L2, L3, L4, L5, L6, L7, away from the outflow port, and the length may be commensurate with a characteristic length, such as characteristic length D1, D2, D3, D4, D5, D6, of the enclosed space, in various implementations. Inflow pressure pin and outflow pressure pout may, for example, be averaged to determine pressure pa in the enclosed space. Thus, pressure pa in the enclosed space is determined from inflow pressure pin and outflow pressure pout detected at the length apart with respect to the enclosed space.


ii) Occlusion of the Outflow Fluid Pathway.


The outflow pressure pout of the outflow fluid deviates from the inflow pressure pin of the inflow fluid by occlusion of the outflow fluid pathway between the enclosed space and the outflow pressure sensor. Because of the occlusion, the outflow pressure pout detected by the outflow pressure sensor is not indicative of pressure pa within the enclosed space and does not generally equal the inflow pressure pin. Occlusion of the outflow fluid pathway may be caused, for example, by exudate, such as exudate 19, that accumulates and hardens within the outflow fluid pathway or liquid that collects at low points in the outflow fluid pathway. That is:














p
in

-

p
out




>
ɛ






and




(
5
)













dp
in

dt



-




dp
out

dt






>
δ




(
6
)








Note that:

pin≈pa but pout≠pa  (7)

iii) Reservoir Filled.


The reservoir of the canister may become filled with liquid, in which case the time rate of change of outflow pressure pout of the outflow fluid increases due to resulting decreased volume within the outflow fluid pathway. Inflow pressure pin is generally equal to the outflow pressure pout. That is:














p
in

-

p
out




<
ɛ






and




(
8
)










dp
out

dt



>
δ




(
9
)








where δ is a sensitivity representing, at least in part, a maximum time rate of change outflow pressure







dp
out

dt





at which the reservoir has capacity (i.e., is not filled).


iv) Leak in Sealing Engagement Between Wound Interface and Skin Surface.


Two bounding exemplary operational conditions are as follows. Note that operational conditions intermediate of these two bounding operational conditions may be possible. These bounding exemplary operational conditions are:


(1) If the leak is large including detachment of the wound interface from the skin surface, then the inflow pressure pin is generally equal to the outflow pressure pout and both are generally equal to ambient pressure pamb. Because the inflow pressure pin and outflow pressure pout are generally unchanged, both










dp
in

dt



<

δ
1



0





and









dp
out

dt




<

δ
2


0





where δ1 and δ2 are sensitivities. Accordingly, pin≈pa≈pout≈pamb so that |pin−pout|<ε.


(2) If the leak is small, then the time rate of change of inflow pressure







dp
in

dt





lags the time rate of change of outflow pressure







dp
out

dt





as net fluid is withdrawn from the enclosed space but inflow pressure pin and outflow pressure equilibrate pout after withdrawal of fluid is competed, which distinguishes this operational condition from occlusion of the outflow fluid pathway. That is:

















dp
out

dt



-




dp
in

dt






>
δ






and




(
10
)










p
in

-

p
out




<
ɛ




(
11
)







As used herein, sensitivity, such as sensitivity δ, δ1, δ2, ε, accounts for roundoff error, truncation error, measurement error, provides damping or hysteresis, and so forth, as would be readily recognized by those of ordinary skill in the art upon study of this disclosure. In various implementations, the sensitivity may be a positive finite value that may approach zero as limited by the physical and digital numeric limitations of the wound therapy apparatus. In various implementations, the sensitivity may be experimentally derived, while, in theory, the sensitivity may approach zero.


The foregoing discussion along with the Figures discloses and describes various exemplary implementations. These implementations are not meant to limit the scope of coverage, but, instead, to assist in understanding the context of the language used in this specification and in the claims. The Abstract is presented to meet requirements of 37 C.F.R. § 1.72(b) only. The Abstract is not intended to identify key elements of the apparatus and methods disclosed herein or to delineate the scope thereof. Upon study of this disclosure and the exemplary implementations herein, one of ordinary skill in the art may readily recognize that various changes, modifications and variations can be made thereto without departing from the spirit and scope of the inventions as defined in the following claims.

Claims
  • 1. A wound therapy apparatus, comprising: a wound interface sealingly securable to a skin surface around a wound bed to form an enclosed space over the wound bed;an inflow port disposed about the wound interface to form a portion of an inflow fluid pathway that communicates an inflow fluid into the enclosed space;an outflow port disposed about the wound interface to form a portion of an outflow fluid pathway that communicates an outflow fluid out of the enclosed space, the outflow port in spaced relation with the inflow port to define a flow path within the enclosed space equivalent to a characteristic length of the enclosed space;an inflow pressure sensor in communication with the inflow fluid pathway to detect an inflow pressure pin of the inflow fluid;an outflow pressure sensor in communication with the outflow fluid pathway to detect an outflow pressure pout of the outflow fluid; andwherein the inflow pressure pin and the outflow pressure pout in combination are indicative of a pressure pa within the enclosed space.
  • 2. The apparatus of claim 1, wherein the enclosed space has a circular shape and the characteristic length is defined as a radius of the circular shape.
  • 3. The apparatus of claim 1, wherein the enclosed space has a rectangular shape and the characteristic length is defined as a diagonal of the rectangular shape.
  • 4. The apparatus of claim 1, wherein the wound interface has a square shape and the characteristic length is defined as a diagonal of the square shape.
  • 5. The apparatus of claim 1, wherein the wound interface has an irregular polygonal shape and the characteristic length is defined as a longest diagonal of the irregular polygonal shape.
  • 6. The apparatus of claim 1, wherein the wound interface has a U shape and the characteristic length is defined from end to end of the U shape.
  • 7. The apparatus of claim 1, further comprising: a controller in operative communication with the inflow pressure sensor and with the outflow pressure sensor to receive data from the inflow pressure sensor and from the outflow pressure sensor, the data indicative of the inflow pressure pin of the inflow fluid, a time rate of change of the inflow pressure
  • 8. The apparatus of claim 7, wherein the operational condition is indicated by |pin−pout|<ε where ε represents a sensitivity and
  • 9. The apparatus of claim 7, wherein the operational condition is indicated by |pin−pout|>ε where ε represents a sensitivity and
  • 10. The apparatus of claim 9, wherein a pulse of the input fluid is input into the enclosed space to clear an occlusion from the outflow fluid pathway upon indication of the operational condition.
  • 11. The apparatus of claim 7, wherein the operational condition is indicated by |pin−pout|<ε and by
  • 12. The apparatus of claim 11, wherein the pressure pa within the enclosed space is decreased below ambient pressure pamb upon indication of the operational condition.
  • 13. The apparatus of claim 7, wherein the operational condition is indicated by
  • 14. A wound therapy apparatus, comprising: a wound interface sealingly securable to a skin surface around a wound bed to form an enclosed space over the wound bed;an inflow fluid pathway that communicates the inflow fluid into the enclosed space;an outflow fluid pathway that communicates an outflow fluid out of the enclosed space;a sensor in communication with the inflow fluid pathway and in communication with the outflow fluid pathway to detect data indicative of the inflow pressure pin of the inflow fluid, a time rate of change of the inflow pressure
  • 15. The apparatus of claim 14, wherein the operational condition is indicated by |pin−pout|<ε where ε represents a sensitivity and
  • 16. The apparatus of claim 14, wherein the operational condition is indicated by |pin−pout|>ε where ε represents a sensitivity and
  • 17. The apparatus of claim 16, wherein a pulse of the input fluid is input into the enclosed space to clear an occlusion from the outflow fluid pathway upon indication of the operational condition.
  • 18. The apparatus of claim 14, wherein the operational condition is indicated by |pin−pout|<ε and by
  • 19. The apparatus of claim 18, wherein the pressure pa within the enclosed space is decreased below ambient pressure pamb upon indication of the operational condition.
  • 20. The apparatus of claim 14, wherein the operational condition is indicated by |pin−pout|<ε and by
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of co-pending U.S. patent application Ser. No. 15/663,709 filed 29 Jul. 2017, and this application is a continuation-in-part of U.S. patent application Ser. No. 15/663,710 filed 29 Jul. 2017, both of which are hereby incorporated by reference in their entireties herein.

US Referenced Citations (131)
Number Name Date Kind
2280915 Johnson Apr 1942 A
3026874 Stevens Mar 1962 A
3300786 Rosenvold et al. Jan 1967 A
4163822 Walter Aug 1979 A
4328799 LoPiano May 1982 A
4399816 Spangler Aug 1983 A
4635618 Munz Jan 1987 A
5086763 Hathman Feb 1992 A
5154697 Loori Oct 1992 A
D364679 Heaton et al. Nov 1995 S
5522794 Ewall Jun 1996 A
5562107 Lavender et al. Oct 1996 A
5607388 Ewall Mar 1997 A
5636643 Argenta et al. Jun 1997 A
5667502 Holtermann Sep 1997 A
5769806 Radow Jun 1998 A
5792090 Ladin Aug 1998 A
5899207 Scheinberg May 1999 A
5980497 Yavitz Nov 1999 A
6062215 Leininger et al. May 2000 A
6098628 Funk Aug 2000 A
6142982 Hunt et al. Nov 2000 A
6222090 Weston Apr 2001 B1
6328709 Hung et al. Dec 2001 B1
6458109 Henley et al. Oct 2002 B1
6484716 Leininger et al. Nov 2002 B1
D469175 Hall et al. Jan 2003 S
6553998 Heaton et al. Apr 2003 B2
D475134 Randolph May 2003 S
6695823 Lina et al. Feb 2004 B1
D488588 Murphy Apr 2004 S
6764462 Risk, Jr. et al. Jul 2004 B2
6767334 Randolph Jul 2004 B1
6767344 Suzuki Jul 2004 B2
6814079 Heaton et al. Nov 2004 B2
6824533 Risk, Jr. et al. Nov 2004 B2
6856821 Johnson Feb 2005 B2
6936037 Bubb et al. Aug 2005 B2
6951553 Bubb et al. Oct 2005 B2
7108683 Zamierowski Sep 2006 B2
7154017 Sigurjonsson et al. Dec 2006 B2
7520866 Stenzler et al. Apr 2009 B2
7532953 Vogel May 2009 B2
7534240 Johnson May 2009 B1
7608066 Vogel Oct 2009 B2
7790945 Watson, Jr. Sep 2010 B1
7837673 Vogel Nov 2010 B2
7909805 Weston Mar 2011 B2
7964766 Blott et al. Jun 2011 B2
D642594 Mattson et al. Aug 2011 S
D648353 Mattson et al. Nov 2011 S
8080702 Blott et al. Dec 2011 B2
8142405 Vogel Mar 2012 B2
8187237 Seegert May 2012 B2
8529532 Pinto et al. Sep 2013 B2
8529548 Blott et al. Sep 2013 B2
8563604 Palefsky et al. Oct 2013 B2
8708982 Lin Apr 2014 B2
8821419 Beek Sep 2014 B1
9782512 Blücher et al. Oct 2017 B2
9907940 Pratt Mar 2018 B2
9913757 Vitaris Mar 2018 B2
9925361 Lin Mar 2018 B2
10729826 Lin Aug 2020 B2
10780201 Lin Sep 2020 B2
20010029956 Argenta et al. Oct 2001 A1
20010041188 Gibbins et al. Nov 2001 A1
20020017304 Heaton et al. Feb 2002 A1
20020143286 Tumey Oct 2002 A1
20020155164 Figley et al. Oct 2002 A1
20030014022 Lockwood et al. Jan 2003 A1
20030021775 Freeman Jan 2003 A1
20030040687 Boynton et al. Feb 2003 A1
20030050594 Zamierowski Mar 2003 A1
20030212357 Pace Nov 2003 A1
20030219469 Johnson et al. Nov 2003 A1
20040006319 Lina et al. Jan 2004 A1
20040010207 Flaherty et al. Jan 2004 A1
20040030304 Hunt et al. Feb 2004 A1
20040073151 Weston Apr 2004 A1
20040093026 Weidenhagen et al. May 2004 A1
20040153032 Garribotto et al. Aug 2004 A1
20040170703 Hoekstra et al. Sep 2004 A1
20050137521 Stenzler Jun 2005 A1
20050220849 Hickey Oct 2005 A1
20050228340 Cleary et al. Oct 2005 A1
20060127462 Canada et al. Jun 2006 A1
20060146234 Bear et al. Jul 2006 A1
20060185670 Loori et al. Aug 2006 A1
20070041960 Freeman et al. Feb 2007 A1
20070118096 Smith et al. May 2007 A1
20070265586 Joshi et al. Nov 2007 A1
20080140029 Smith et al. Jun 2008 A1
20090258058 Thomas et al. Oct 2009 A1
20090312723 Blott et al. Dec 2009 A1
20100069858 Olson Mar 2010 A1
20100268128 Randolph Oct 2010 A1
20100298792 Weston et al. Nov 2010 A1
20110160686 Ueda et al. Jun 2011 A1
20120029449 Khosrowshahi Feb 2012 A1
20120316538 Heiser et al. Dec 2012 A1
20130053795 Coulthard et al. Feb 2013 A1
20130053806 Guillo et al. Feb 2013 A1
20130165837 Addison et al. Jun 2013 A1
20130211318 Croizat et al. Aug 2013 A1
20130231623 Richard Sep 2013 A1
20130303975 Gvodas, Jr. Nov 2013 A1
20140081192 Wenske et al. Mar 2014 A1
20140114268 Auguste et al. Apr 2014 A1
20140155790 Argenta et al. Jun 2014 A1
20140207027 Navia et al. Jul 2014 A1
20140309574 Cotton Oct 2014 A1
20150005678 Wall Jan 2015 A1
20150088085 Rovaniemi Mar 2015 A1
20150119832 Locke Apr 2015 A1
20150216733 Allen et al. Aug 2015 A1
20160000610 Riesinger Jan 2016 A1
20160038626 Locke et al. Feb 2016 A1
20160074232 Vitaris et al. Mar 2016 A1
20160128894 Horton et al. May 2016 A1
20160166781 Sarangapani et al. Jun 2016 A1
20160256665 Doshi et al. Sep 2016 A1
20160262944 Shmuelovitch et al. Sep 2016 A1
20170007751 Hartwell et al. Jan 2017 A1
20170119940 Quisenberry May 2017 A1
20180050137 Ryu Feb 2018 A1
20190030223 Lin Jan 2019 A1
20190030224 Lin Jan 2019 A1
20190030226 Lin Jan 2019 A1
20190133830 Bishop et al. May 2019 A1
20190151156 Kieswetter et al. May 2019 A1
Foreign Referenced Citations (40)
Number Date Country
2010101399472 Jan 2016 CH
102008373 Apr 2011 CN
101969902 Feb 2013 CN
102985096 Mar 2013 CN
104024498 Sep 2014 CN
106659590 May 2017 CN
0206646 Dec 1986 EP
0940131 Sep 1999 EP
1219311 Jul 2002 EP
1018967 Aug 2004 EP
1674898 Jun 2006 EP
1901686 Mar 2008 EP
2995324 Mar 2016 EP
3156016 Apr 2017 EP
3157484 Feb 2020 EP
288220 Aug 1928 GB
2265314 Sep 1993 GB
2329127 Aug 2000 GB
2351025 Dec 2000 GB
2365350 Feb 2002 GB
2496310 Oct 2015 GB
9605873 Feb 1996 WO
0059418 Oct 2000 WO
0059424 Oct 2000 WO
03049660 Jun 2003 WO
2004060148 Jul 2004 WO
2003092620 Dec 2004 WO
2005009488 Feb 2005 WO
2005046761 May 2005 WO
2006081403 Aug 2006 WO
2009141820 Nov 2009 WO
2011130246 Oct 2011 WO
2013066694 May 2013 WO
2013123005 Aug 2013 WO
2015193257 Dec 2015 WO
2019027806 Feb 2019 WO
2019027807 Feb 2019 WO
2019027808 Feb 2019 WO
2019027809 Feb 2019 WO
2019027810 Feb 2019 WO
Non-Patent Literature Citations (43)
Entry
US 10,688,227, 07/2017, Lin (withdrawn)
Application Guide: Pico multisite with softport technology applied to the heel, PCPE-48-0717-UE, Smith & Nephew, Inc. 2017.
Avance® Clinician's Guidelines, Revision Feb. 2017, Molnlycke Health Care US, LLC, Norcross, GA 30092.
BASF: Superabsorbent Fabric Keeps Feet Dry in All Weathers; Luquafleece from BASF in the IQ-Text Ventilation Element Clams Up in Tight in Wet Conditions, Oct. 7, 2008 (Year: 2008).
Borgquist, O., R. Ingemansson, M Malmsjö, Effects of negative pressure wound therapy on regional blood flow, wound contraction and fluid removal—Examining low pressure levels, intermittent and variable therapy, 24th Annual Clinical Symposium on Advances in Skin & Wound Care, San Antonio, Texas, USA—Oct. 22-25, 2009.
Borgquist, Ola, et al. Wound Edge Microvascular Blood Flow during Negative-Pressure Woulnd Therapy: Examining the Effects of Pressures from −10 to −175 mmHg, PRSJournal, vol. 125, No. 2, 2010, 502-509.
Cardinal Health NPWT Pro Family, Cardinal Health, Waukegan, IL, 2015.
Cardinal Health SVED Clinician User Manual, Cardinal Health, Waukegan, IL, 2015.
Cardinal Health SVED Patient User Manual, Cardinal Health, Waukegan, IL, 2015.
Cardinal Health SVED, “Clinitial Quick Reference Guide”, Cardinal Health, the Netherlands, 2015, 2 pages.
Chanden K. Sen, Wound healing essentials: Let there be oxygen, Wound Rep Reg (2009) 17 1-18.
Eriksson, et al., Wet wound healing: from laboratory to patients to gene therapy, The American Journal of Surgery 188 (Suppl to Jul. 2004) 36S-41S.
EZCare Negative Pressure Wound Therapy, V1STA Negative Pressure Wound Therapy, Negative Pressure Wound Therapy Clinical Guidelines, BS-0039-0808, Smith & Nephew.
Final Rejection, U.S. Appl. No. 15/663,708, filed Apr. 15, 2020, 20 pages.
Final Rejection, U.S. Appl. No. 15/663,709, filed Jun. 5, 2020.
Final Rejection, U.S. Appl. No. 15/663,710, filed Nov. 25, 2019.
Final Rejection, U.S. Appl. No. 15/663,713, filed Jan. 10, 2020, 9 pages.
Final Rejection, U.S. Appl. No. 15/663,714, filed Feb. 3, 2020, 15 pages.
Ghatak, Schlanger, Ganesh, Lambert, Gordillo, Martinsek, and Roy, A Wireless Electroceutical Dressing Lowers Cost of Negative Pressure Wound Therapy, Adv Wound Care (New Rochelle) 4(5): 302-311, May 2015.
International Search Report for International Application No. PCT/US2018/043953 dated Oct. 9, 2018.
International Search Report for International Application No. PCT/US2018/043955 dated Oct. 17, 2018.
International Search Report for International Application No. PCT/US2018/043957 dated Oct. 19, 2018.
International Search Report for International Application No. PCT/US2018/043959 dated Oct. 15, 2018.
International Search Report for International Application No. PCT/US2018/043962 dated Oct. 16, 2018.
ITI Brings Hospitals New Value Model For Wound Care, Innovative Therapies, Inc. Copyright 2013 PR Newswire.
Leionkiewicz, M. Pawlaczyz, et al. Age-dependent biomechanical properties of the skin. Postepy Dermatol Alergol. 2013;30(5):302-306 (2013).
Malsmjo, MD, et al., Negative pressure wound therapy using gauze or polyurethane open cell foam: similar effects on would edge microvascular blood flow, Lund University, 1 page.
Merriam, Webster, Definition of Rigid 2022.
Niederauer, Mark Q. et al. Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study, J. Wound Care, N. American Supplement, vol. 27, No. 9, Sep. 2018.
Non Final Rejection, U.S. Appl. No. 15/663,710, dated Jul. 11, 2019.
Non-Final Office Action, U.S. Appl. No. 15/663,708, dated Nov. 7, 2019.
Non-Final Rejection, U.S. Appl. No. 15/663,708, dated Nov. 7, 2019, 31pages.
Non-Final Rejection, U.S. Appl. No. 15/663,709, dated Oct. 10, 2019.
Non-Final Rejection, U.S. Appl. No. 15/663,713, dated Jun. 28, 2019.
Non-Final Rejection, U.S. Appl. No. 15/663,714, dated Sep. 13, 2019.
Pawlacqyk, Mariola, et al. Age-dependent biomechanical properties of the skin, Postepy Dermatol Alergol 2013,30(5):302-306;302-306.
Prevena Incision Management System, Clinician Guide, 390061 Rev C, KCI Licensing Inc., 2009.
Prevena Incision Management System, Product Monograph, KCI Licensing Inc., 2010.
Prospera Negaitve Pressure Wound Therapy, Pro-I, Advancing the Art and Science of NPWT, Prospera, Ft. Worth, Tx, 2008. MR-125-04/08.
Renasys Negative Pressure Wound Therapy, Pico Single Use Negative Pressure Wound Therapy System, NPCE-48-0613-NAE, Smith & Nephew, Inc., 2013.
V.A.C. Ulta Quick Reference Guide, KCI Licensing Inc., 2013.
V.A.C.Ulta™ Negative Pressure Wound Therapy System, KCI Licensing Inc., Apr. 17, 2016.
Vinidex, PVC Properties, accessed from URL: https://www.vinidex.com.au/technical-resources/material-properties/pvc-properties (2022), pp. 19.
Related Publications (1)
Number Date Country
20210001022 A1 Jan 2021 US
Continuation in Parts (2)
Number Date Country
Parent 15663709 Jul 2017 US
Child 17026822 US
Parent 15663710 Jul 2017 US
Child 17026822 US